The FDA approved dihydroergotamine (DHE) mesylate injection (Brekiya) to treat acute migraine (with or without aura) and ...

Almost a third of Americans are more than a year behind in cancer screening, more than half of them because of out-of-pocket ...

Since SGLT2 inhibitors primarily work on the renal component as its mechanism of action, by flushing sugar out through the ...

President Trump incorrectly placed the blame for high prescription drug prices in the U.S. on foreign nations, making the ...

The blood test, known as the Lumipulse G pTau 217/β-Amyloid 1-42 Plasma Ratio, can be used to detect amyloid plaques ...

The lawsuit filed April 1 by 23 states and the District of Columbia sought to immediately halt $ 11 billion in cuts, alleging ...

ORLANDO -- Fracture risk may be higher after bariatric surgery than after treatment with weight-loss drugs, propensity-score ...

Beyond 2 years, CABG with flow assessment was associated with a higher risk for new coronary angiography and new ...

At the recent American Urological Association (AUA) annual meeting, focal therapies for localized prostate cancer took center ...

The action establishes belzutifan as the only approved oral therapy for PPGL. The approval stipulates use in adults and children 12 years or older with locally advanced, unresectable, or metastatic ...